Ning et al. (2016) tried to target CD133 with antibody-conjugated SN-38-loaded nanoparticles, which illustrated a significant efficacy in stopping the growth and reducing the recurrence in positive CD133 colorectal cancer stem cells [43]. The gene discussed is PROM1; the disease is colorectal cancer.